| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -2,626 | -3,167 | -943 | -3,609 |
| Credit loss expense | NaN | 0 | 44 | 0 |
| Depreciation | 96 | 103 | 98 | 185 |
| Amortization of right-of-use assets | 62 | 61 | 61 | 118 |
| Provision for product warranties | -78 | -97 | -268 | -138 |
| Stock-based compensation | 70 | 76 | 73 | 146 |
| Income tax payable | NaN | NaN | NaN | 0 |
| Deferred income taxes | -1,607 | 158 | -1,427 | -613 |
| Accounts receivable | -2,463 | -3,295 | -3,242 | -7,109 |
| Inventories | 2,368 | 922 | 537 | 3,176 |
| Prepaid inventory | 956 | 181 | -1,340 | -666 |
| Other current assets | 24 | -352 | -314 | 842 |
| Other noncurrent assets | -74 | -178 | 283 | -117 |
| Accounts payable and accrued expenses | 1,349 | -2,276 | 254 | 554 |
| Operating lease liability | -63 | -63 | -61 | -118 |
| Deferred revenue | -209 | 183 | 108 | -35 |
| Product warranties | 92 | 101 | 256 | 200 |
| Net cash used in operating activities | -3,753 | -2,207 | 2,295 | 440 |
| Acquisition of property and equipment | 3 | 158 | 4 | 34 |
| Net cash used in investing activities | -3 | -158 | -4 | -34 |
| Exercise of stock options | NaN | NaN | NaN | 0 |
| Repurchase of common stock | NaN | 0 | 0 | 300 |
| Withholding taxes on stock-based compensation | NaN | 5 | NaN | NaN |
| Net cash (used in) provided by financing activities | NaN | -5 | 0 | -300 |
| Net decrease in cash and cash equivalents | -3,756 | -2,370 | 2,291 | 106 |
| Cash and cash equivalents beginning of period | 22,083 | 24,453 | 22,056 | NaN |
| Cash and cash equivalents end of period | 18,327 | 22,083 | 24,453 | NaN |
Sensus Healthcare, Inc. (SRTS)
Sensus Healthcare, Inc. (SRTS)